Viread’s explosive growth to KRW 100 billion prescriptions
‘Viread,’ the new star of the hepatitis B treatment market, will list its name for the gigantic products which record KRW 100 billion outpatient prescriptions.
Until the last year, products exceeding annual KRW 100 billion outpatient prescriptions were only ‘Baraclude’ and ‘Lipitor.’
By the 3rd...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
